UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000013700
Receipt number R000015994
Scientific Title Surveillance for esophageal cancer using NBI endoscopy
Date of disclosure of the study information 2014/04/12
Last modified on 2017/10/16 18:07:23

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Surveillance for esophageal cancer using NBI endoscopy

Acronym

NBI surveillance

Scientific Title

Surveillance for esophageal cancer using NBI endoscopy

Scientific Title:Acronym

NBI surveillance

Region

Japan


Condition

Condition

Superficial esophageal squamous cell carcinoma

Classification by specialty

Gastroenterology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

We investigate whether scheduled endoscopic surveillance is sufficient to identify metachronous cancer earlier enough for curative treatment by endoscopic resection

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

5 years control rate by endoscopic surveillance and endoscopic resection

Key secondary outcomes

incident rate of metachronous esophageal cancer, 5 years survival rate, accuracy of magnified NBI endoscopy, clinical and pathological characteristics of metachronous esophageal cancer


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Diagnosis

Type of intervention

Device,equipment

Interventions/Control_1

Magnified NBI endoscopy

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >=

Gender

Male and Female

Key inclusion criteria

patients who received endoscopic resection for esophagealcancer and diagnosed curative resection within depth of T1a-LPM.

Key exclusion criteria

(1) esophageal and pharyngeal stricture (2) previous surgical resection or chemotherapy, radiotherapy, or chemoradiotherapy for esophageal SCC
(3) patients with active malignant cancer or presence of serious complications (liver, kidney, heart, blood, or metabolic disorders)
(4) other reasons which made the subject ineligible to participate in this study, at the discretion of the chief investigator.

Target sample size

100


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yasuaki Nagami

Organization

Osaka City University Graduate School of Medicine

Division name

Department of Gastroenterology

Zip code


Address

1-4-3, Asahimachi, Abeno-ku, Osaka, 545-8585, Japan

TEL

06-6645-3811

Email

m1151493@med.osaka-cu.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Yasuaki Nagami

Organization

Osaka City University Graduate School of Medicine

Division name

Department of Gastroenterology

Zip code


Address

1-4-3, Asahimachi, Abeno-ku, Osaka, 545-8585, Japan

TEL

06-6645-3811

Homepage URL


Email

m1151493@med.osaka-cu.ac.jp


Sponsor or person

Institute

Osaka City University Graduate School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Osaka City University Graduate School of Medicine

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

大阪市立大学医学部附属病院 消化器内科


Other administrative information

Date of disclosure of the study information

2014 Year 04 Month 12 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2014 Year 03 Month 31 Day

Date of IRB


Anticipated trial start date

2014 Year 04 Month 01 Day

Last follow-up date

2022 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2014 Year 04 Month 12 Day

Last modified on

2017 Year 10 Month 16 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000015994


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name